95%Confidence
0Views
FDASource
2026-03-15Date
Summary
A second Class II recall for Bio Glo Fluorescein Sodium Ophthalmic Strips reinforces ongoing manufacturing issues at Omni Lens, affecting HUB Pharmaceuticals. This repeated failure indicates systemic quality problems that could lead to regulatory scrutiny and loss of market trust.
Actionable: Assess the cumulative impact of multiple recalls on HUB Pharmaceuticals' operations and evaluate competitive positioning in the ophthalmic strip market.
AI Confidence: 95%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productBio Glo Fluorescein Sodium Ophthalmic Strips USP, 300 diagnostic strips, Manufactured Omni Lens Pvt Ltd 5 - Samruddhi, Opp. Sakar - III, Navrangpura,
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now